The relationship between GLP-1 receptor agonist weight loss injections and kidney stone formation is not definitively established in current medical literature
Common indicators include: Elevated homocysteine levels (above 10-15 mol/L) Chronic fatigue and low energy Anxiety, depression, or brain fog Hormonal imbalances (PMS, infertility, irregular periods) Recurrent miscarriages or pregnancy complications Cardiovascular issues (high blood pressure, blood clots) Digestive problems (IBS, bloating, food sensitivities) Chronic inflammation or autoimmune conditions Many people discover they have an MTHFR mutation after experiencing unexplained health issues or through genetic testing ordered by their healthcare provider
Brain and mood peptides are frequently paired with hormone optimization, NAD+ IV therapy, and cortisol management protocols for a more comprehensive approach.
FIGURE 4 4.5 Inhibition of glucagon release Considered an anti-insulin hormone, 2022 marks the 100th anniversary of the discovery of glucagon, which is produced in islet cells through the processing of prohormone-converting enzyme 2 (Pcsk2) and acts through glucagon receptor (GCGR) (Hayashi, 2011)